
Why is everyone wearing weighted vests? I tried one for two weeks
Celebrities have been sporting them on walks, Peloton instructors are making videos explaining how to use them, and influencers are peddling them on TikTok. Publications have written about their growing popularity among 'the menopause set', as Allure put it, because of their supposed ability to help with muscle strength and bone density as one ages.
'It really has gotten so much attention lately,' says Dr Elaina Manolis, a physical therapist and clinical professor at Northeastern University. The practice used to be called 'rucking', she notes, because people would walk with heavy rucksacks.
One reason for this spike is that the vests don't look so much like bulky backpacks anymore, Manolis suspects: 'They're sleek and cute,' she says. She also believes it's part of a bigger societal trend. 'Culture has shifted so much for the positive in women's health, and in understanding the importance of strength training and bone density,' she says.
So are weighted vests the miracle workout upgrade some claim? I tried one for two weeks, and asked experts for advice.
They are vests that are weighed down with iron sand or small weights. 'They can be thought of as 'hyper-gravity',' says Dr Abbi Lane, assistant professor of applied exercise science at the University of Michigan. 'They add a little bit more weight and resistance.'
Typically, they weigh anywhere from five to 30lbs (2.26 to 13.6kg), and are worn across the shoulders and upper torso. Some are small, with straps across the chest. Others are bigger, cover most of the torso and look disconcertingly like bulletproof vests.
'Start with a vest that's no more than five to 10% of your body weight, and build from there,' says Dr Mary Claire Haver, obstetrician-gynecologist and medical advisory board member of Let's Talk Menopause.
I ordered a 16lb (7.25 kg) vest by a brand called Prodigen that seemed relatively comfortable and wouldn't make me look like I was on my way to a gun range.
Weighted vests are different to other equipment in that they can be worn pretty much anywhere and at any time.
'Whereas you might do resistance training in a gym for 30 minutes twice a week, you could put on the weighted vest during other activities,' says Lane.
It's still best to limit one's use though, especially in the beginning.
'I don't recommend it for everyday use,' says Manolis. Most daily tasks involve a lot of bending and stretching, and adding weight raises the risk of injury.
Manolis recommends wearing a vest when walking – which she calls 'a very underrated exercise as it is' – because you are in an upright posture and the potential for injury is much lower.
If you are confident in the vest, you can also use it for 'light aerobics, strength training and even short bouts of running', says Haver. Make sure your joints can tolerate the load though. Start by wearing the vest for a short period of time, then build up. 'Aim for 20-30 minutes a day, and listen to your body,' says Haver.
Twice a week, for two weeks, I wore my vest for my current favorite physical activity: walking on the treadmill in the air conditioned gym while watching Vera on my iPad. When I first strapped it on, the vest felt heavy but oddly comforting – like a thunder shirt for dogs.
As I started walking, I was surprised by how off-balance I felt. It took me a few minutes to find my stride, and holding myself upright and centered required more core strength than I had expected. By the time my 30 minutes was up, DCI Vera Stanhope had realized that all was not as it seemed in her murder case, and I was breathing noticeably harder than usual.
Why did it feel more challenging? I have previously weighed 16lbs more than I do now, and I don't recall feeling more tired when I walked.
When you wear a vest, 'the weight is not distributed throughout the body,' explains Lane. 'When I was 16lbs heavier, my legs and arms were bigger too. When you have the vest, it's all in one place and you have to adjust your center of mass,' she says.
Sign up to Well Actually
Practical advice, expert insights and answers to your questions about how to live a good life
after newsletter promotion
This challenges your balance, but it's important that the vest not be so heavy that it requires you to significantly change your gait. 'That's how injuries can happen,' she says.
Over time, I felt less off-kilter when I wore the vest. My walks felt more intense than usual, but not unpleasant.
Weighing down your body with a weighted vest has a number of benefits, says Manolis. When your body is heavier, moving requires more muscle, she explains. And over time, as more muscle develops, strength improves. The greater weight will also require more energy to move, and thus your body will burn more calories.
Some research shows that long-term use of weighted vests can prevent bone loss in postmenopausal women, a population particularly at risk for low bone density and resulting conditions like osteopenia and osteoporosis. Manolis suggests that this may be because the added top-down pressure that a vest places on one's skeletal system can improve how quickly bones repair themselves.
Most studies on weighted vests and bone density have been small though, warns Lane – fewer than 20 people. The biggest study on the topic had 150 participants. The one-year, randomized control trial explored whether exercising with a weighted vest could offset bone loss in older adults who were trying to lose weight. It did not.
'The research here is not super fleshed out yet,' Lane says.
The flexibility and affordability of weighted vests mean they can still be a useful piece of equipment. 'We're finally talking about muscle and bone loss in midlife women,' says Haver. 'And weighted vests are a simple, affordable way to help combat that.'
Ideally though, they would be used in conjunction with other forms of cardio and strength training. 'I think of things like weighted vests as the cherry on top,' says Lane. 'Potentially beneficial, but nothing replaces aerobic and resistance exercise.'
The greatest risks come from wearing a vest that is too heavy, or wearing one for too long.
'It can cause joint strain, poor posture, or even back or knee pain,' says Haver. Proper fit and gradual progression are key, she says. And if you ever feel discomfort, stop. 'Don't push through pain,' she warns.
I've worn my weighted vest a few more times since my two-week trial. I don't love how sweaty it makes me. I'm also not sure about the best way to clean it as the manufacturer didn't provide any instructions. (I've been using cleaning wipes – please don't tell me if this is wrong.) But it is a nice way to add some difficulty and novelty to my Vera walks.
Still, I don't think it's going to become a staple in my routine. I strength train several times a week, and a set of heavy squats feels like a more effective, challenging and satisfying way of strengthening my legs and bones than walking with 16lbs of extra weight.
I did enjoy that it made me look like an action movie hero though. When I asked my partner how I looked in it, he responded: 'Tactical.' That's way cooler than my usual gym look: sweaty 30-something woman in a Rainforest Cafe T-shirt.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
40 minutes ago
- The Guardian
Tennessee set to execute inmate despite concerns heart device could prolong ordeal
Tennessee is set to execute an inmate on Tuesday without deactivating his implanted defibrillator, as uncertainty lingers about whether the device will shock his heart when a lethal drug takes effect. Barring a late reprieve requested from the governor or the courts, Byron Black's execution will go forward after a legal back-and-forth over whether the state would need to turn off his implantable cardioverter-defibrillator, or ICD. The non-profit Death Penalty Information Center said it's unaware of any other cases in which an inmate was making similar claims to Black about ICDs or pacemakers. The execution would be Tennessee's second since May, after a pause for five years, first because of Covid-19 and then because of missteps by the Tennessee department of correction. Twenty-seven men have died by court-ordered execution so far this year in the US, and nine other people are scheduled to be put to death in seven states during the remainder of 2025. The number of executions this year exceeds the 25 carried out last year and in 2018. It is the highest total since 2015, when 28 people were put to death. Black, 69, is in a wheelchair, suffering from dementia, brain damage, kidney failure, congestive heart failure and other conditions, his attorneys have said. In mid-July, a trial court judge agreed with Black's attorneys that officials must have the instrument deactivated to avert the risk that it could cause unnecessary pain and prolong the execution. But the state supreme court intervened on 31 July to overturn that decision, saying the other judge lacked the authority to order the change. The state has disputed that the lethal injection would cause Black's defibrillator to shock him. Even if shocks were triggered, Black wouldn't feel them, the state has added. Black's attorneys have countered that even if the lethal drug being used, pentobarbital, renders someone unresponsive, they aren't necessarily unaware or unable to feel pain. Black was convicted in the 1988 shooting deaths of his girlfriend Angela Clay, 29, and her two daughters, Latoya Clay, 9, and Lakeisha Clay, 6. Prosecutors said he was in a jealous rage when he shot the three at their home. At the time, Black was on work-release while serving time for shooting Clay's estranged husband. Linette Bell, whose sister and two nieces were killed, recently told WKRN-TV: 'He didn't have mercy on them, so why should we have mercy on him?' 'It feels like it is never-ending,' Bell told the news outlet. 'They aren't even resting in their own grave.' An implantable cardioverter-defibrillator is a small, battery-powered electronic device that is surgically implanted in the chest, typically near the left collarbone. It serves as a pacemaker and an emergency defibrillator. Black's attorneys say the only way to be sure it's off is for a doctor to place a programming device over the implant site, sending it a deactivation command, with no surgery required. The legal case also spurred a reminder that most medical professionals consider participation in executions a violation of health care ethics. While the judge's order to deactivate the device was in place, state officials said Nashville General Hospital practitioners would do the procedure the day before at the hospital, but wouldn't travel to the prison on execution day as the court required. The judge offered some leeway, allowing the procedure at the hospital on the morning of the execution. But Nashville General then released a statement saying the state's contractor didn't reach out to proper hospital leadership and that there had been no agreement to do the work. In recent years, Black's legal team has also tried and failed to get a new hearing over whether he is intellectually disabled and ineligible for the death penalty under US supreme court precedent. His attorneys have said that if they had delayed a prior attempt to seek his intellectual disability claim, he would have been spared under a 2021 state law. Nashville District Attorney Glenn Funk contended in 2022 that Black is intellectually disabled and deserves a hearing under that 2021 law, but the judge denied it. That is because an inmate can't get an intellectual disability hearing under the 2021 law if they have already filed a similar request and a court has ruled on it 'on the merits'. In Funk's attempt, he focused on input from an expert for the state in 2004 who determined back then that Black didn't meet the criteria for what was then called 'mental retardation'. But she concluded that Black met the new law's criteria for a diagnosis of intellectual disability. Black has also been seeking a determination by the courts that he is incompetent to be executed.


Reuters
2 hours ago
- Reuters
Pfizer raises annual profit forecast after upbeat second quarter
Aug 5 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab on Tuesday raised its full-year profit forecast on strong demand for its heart disease drug, Vyndaqel, and blood thinner, Eliquis, after its second-quarter results benefited from a weaker dollar. Pfizer said the new forecast includes a one-time charge of 20 cents per share related to its recent licensing deal with China's 3SBio ( opens new tab for experimental cancer treatment. Shares of the New York-based company rose 2.8% to $24.19 in premarket trading. The drugmaker's results come as the pharmaceutical industry faces intense pressure from President Donald Trump's administration to lower drug prices, while preparing for 15% tariffs on imports from the European Union. Pfizer has said it has enough manufacturing capacity across its 10 sites in the United States to mitigate any impact from tariffs and is open to shifting some production to these existing facilities. Investors are also closely monitoring potential disruptions to Pfizer and other companies' vaccine portfolio from policy changes under RFK Jr., a known vaccine skeptic. Vaccines account for about 20% of Pfizer's revenues. Pfizer now expects to earn $2.90 to $3.10 per share on an adjusted basis in 2025, compared with its previous expectations of $2.80 to $3.00 per share. Total sales for the quarter ended June 29 came in at $14.65 billion, including a $22 million favorable impact from foreign exchange, Pfizer said. Analysts, on average, were expecting revenues of $13.56 billion, according to LSEG data. Quarterly sales of its heart disease drug, sold under brand names Vyndaqel and Vyndamax, were $1.62 billion, slightly above estimates of $1.59 billion. Revenue from Eliquis, on which it partners with Bristol Myers Squibb (BMY.N), opens new tab, was $2 billion, while analysts were expecting $1.94 billion. On an adjusted basis, Pfizer earned 78 cents per share in the second quarter, compared with analysts' expectations of 58 cents per share.


Reuters
2 hours ago
- Reuters
Pfizer raises annual profit forecast
Aug 5 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab raised its full-year profit forecast on Tuesday after reporting better-than-expected results for the second quarter, boosted by strong demand for its heart disease drug, Vyndaqel, and blood thinner, Eliquis. The drugmaker now expects to earn $2.90 to $3.10 per share on an adjusted basis in 2025, compared with its previous expectations of $2.80 to $3.00 per share. Shares of the drugmaker rose 2.4% in premarket hours. Pfizer said the new forecast includes an impact of 20 cents per share related to its recent licensing deal with China's 3SBio ( opens new tab for experimental cancer treatment. Pfizer's results come at a time when the pharmaceutical industry is under pressure from President Donald Trump's administration to lower drug prices and is gearing up for 15% tariffs on imports from the European Union. The drugmaker has said it had enough manufacturing capacity across its 10 sites in the United States to mitigate any impact from tariffs and is open to shifting some production to these existing facilities. Investors are also closely monitoring potential disruptions to Pfizer and other companies' vaccine portfolio from policy changes under RFK Jr., a known vaccine skeptic. Vaccines account for about 20% of Pfizer's revenues. On an adjusted basis, Pfizer earned 78 cents per share in the second quarter, compared with analysts' expectations of 58 cents per share, according to LSEG data.